Glenmark Pharmaceuticals Sees Significant Rise in Open Interest and Trading Activity
Glenmark Pharmaceuticals Ltd. has seen a significant rise in open interest, reaching 33,947 contracts, alongside a trading volume of 36,596 contracts. The stock has outperformed its sector and is trading above key moving averages, reflecting strong market engagement and robust performance metrics within the Pharmaceuticals and Biotechnology sector.
Glenmark Pharmaceuticals Ltd. has experienced a notable increase in open interest today, signaling heightened activity in the stock. The latest open interest stands at 33,947 contracts, up from the previous 30,409, marking a change of 3,538 contracts or an 11.63% increase. The trading volume for the day reached 36,596 contracts, contributing to a futures value of approximately Rs 32,643.68 lakhs and an options value of Rs 26,106.74 crore, bringing the total value to Rs 38,411.41 lakhs.In terms of price performance, Glenmark Pharmaceuticals outperformed its sector by 2.29%, with the stock hitting an intraday high of Rs 2,110, reflecting a 2.83% increase. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. Additionally, delivery volume has surged by 47.24% compared to the 5-day average, suggesting increased trading activity.
With a market capitalization of Rs 58,500 crore, Glenmark Pharmaceuticals continues to demonstrate robust performance metrics within the Pharmaceuticals and Biotechnology sector. The increase in open interest and trading volume highlights the stock's active engagement in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Activity
Glenmark Pharmaceuticals Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum
Most Read
